GB201207297D0 - Analytical methods and arrays for use in the same - Google Patents

Analytical methods and arrays for use in the same

Info

Publication number
GB201207297D0
GB201207297D0 GB201207297A GB201207297A GB201207297D0 GB 201207297 D0 GB201207297 D0 GB 201207297D0 GB 201207297 A GB201207297 A GB 201207297A GB 201207297 A GB201207297 A GB 201207297A GB 201207297 D0 GB201207297 D0 GB 201207297D0
Authority
GB
United Kingdom
Prior art keywords
arrays
same
analytical methods
methods
mutz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201207297A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SenzaGen AB
Original Assignee
SenzaGen AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SenzaGen AB filed Critical SenzaGen AB
Priority to GB201207297A priority Critical patent/GB201207297D0/en
Publication of GB201207297D0 publication Critical patent/GB201207297D0/en
Priority to PCT/IB2013/053321 priority patent/WO2013160882A1/en
Priority to HK15111843.9A priority patent/HK1211059A1/xx
Priority to BR112014026582A priority patent/BR112014026582A2/pt
Priority to US14/396,422 priority patent/US20150111771A1/en
Priority to EP13781556.9A priority patent/EP2841599A4/en
Priority to IN2397MUN2014 priority patent/IN2014MN02397A/en
Priority to KR20147033326A priority patent/KR20150016523A/ko
Priority to CA2871350A priority patent/CA2871350A1/en
Priority to CN201380031747.7A priority patent/CN104685067A/zh
Priority to US15/624,955 priority patent/US20170283874A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB201207297A 2012-04-26 2012-04-26 Analytical methods and arrays for use in the same Ceased GB201207297D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB201207297A GB201207297D0 (en) 2012-04-26 2012-04-26 Analytical methods and arrays for use in the same
CN201380031747.7A CN104685067A (zh) 2012-04-26 2013-04-26 用于鉴定能够诱导呼吸道致敏的物质的方法和用于该方法中的阵列和分析试剂盒
US14/396,422 US20150111771A1 (en) 2012-04-26 2013-04-26 Method for Identifying Agents Capable of Inducing Respiratory Sensitization and Array and Analytical Kits for Use in the Method
HK15111843.9A HK1211059A1 (en) 2012-04-26 2013-04-26 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method
BR112014026582A BR112014026582A2 (pt) 2012-04-26 2013-04-26 método para identificar agentes capazes de induzir a sensibilização respiratória e matriz e kits analíticos para uso no método
PCT/IB2013/053321 WO2013160882A1 (en) 2012-04-26 2013-04-26 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method.
EP13781556.9A EP2841599A4 (en) 2012-04-26 2013-04-26 METHOD OF IDENTIFYING AGENTS FOR INDUCTING RESPIRATORY SENSITIZATION, AND ARRANGEMENT AND ANALYSIS KITS FOR USE IN THE METHOD
IN2397MUN2014 IN2014MN02397A (https=) 2012-04-26 2013-04-26
KR20147033326A KR20150016523A (ko) 2012-04-26 2013-04-26 호흡기 감작성을 유도할 수 있는 물질을 확인하는 방법 및 그 방법에서 사용하기 위한 어레이 및 분석 키트
CA2871350A CA2871350A1 (en) 2012-04-26 2013-04-26 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method
US15/624,955 US20170283874A1 (en) 2012-04-26 2017-06-16 Analytical Methods and Arrays for Use in the Same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201207297A GB201207297D0 (en) 2012-04-26 2012-04-26 Analytical methods and arrays for use in the same

Publications (1)

Publication Number Publication Date
GB201207297D0 true GB201207297D0 (en) 2012-06-06

Family

ID=46261886

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201207297A Ceased GB201207297D0 (en) 2012-04-26 2012-04-26 Analytical methods and arrays for use in the same

Country Status (10)

Country Link
US (2) US20150111771A1 (https=)
EP (1) EP2841599A4 (https=)
KR (1) KR20150016523A (https=)
CN (1) CN104685067A (https=)
BR (1) BR112014026582A2 (https=)
CA (1) CA2871350A1 (https=)
GB (1) GB201207297D0 (https=)
HK (1) HK1211059A1 (https=)
IN (1) IN2014MN02397A (https=)
WO (1) WO2013160882A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201421207D0 (en) * 2014-11-28 2015-01-14 Senzagen Ab Analytical methods and arrays for use in the same
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
JP7023857B2 (ja) * 2016-03-23 2022-02-22 センソシェン アクティエ ボラーグ 解析方法およびそれに用いるアレイ
TWI793151B (zh) 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
GB201715445D0 (en) 2017-09-25 2017-11-08 Senzagen Ab Novel cell line and uses thereof
CN109828113A (zh) * 2017-11-23 2019-05-31 复旦大学附属肿瘤医院 PAPSS1在制备筛选α干扰素治疗肝癌敏感人群标志物的制剂中的用途
CN108304912B (zh) * 2017-12-29 2020-12-29 北京理工大学 一种运用抑制信号实现脉冲神经网络监督学习的系统和方法
AR116109A1 (es) 2018-07-10 2021-03-31 Novartis Ag Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
DK3820573T3 (da) 2018-07-10 2023-10-23 Novartis Ag 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidin-2,6-dion-derivativer og anvendelse deraf ved behandling af ikaros family zinc finger 2 (ikzf2)-afhængige sygdomme
WO2020141204A2 (en) 2019-01-03 2020-07-09 Senzagen Ab Analytical methods and arrays for use in the same
EP4130739A4 (en) * 2020-03-25 2023-06-14 FUJIFILM Corporation METHOD FOR MEASUREMENT OF RESPIRATORY SENSITIZATION AND REAGENT FOR MEASUREMENT OF RESPIRATORY SENSITIZATION
CN111596067B (zh) * 2020-06-03 2021-06-22 四川大学华西第二医院 Zc3h8在pop早期预警、诊断、预后评估中的应用和产品
CA3222964A1 (en) * 2021-07-02 2023-01-05 Regeneron Pharmaceuticals, Inc. Methods of treating asthma with solute carrier family 27 member 3 (slc27a3) inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
CA2608167C (en) * 2005-05-12 2012-05-01 Corporation Nuvolt Inc. Current sensor
EP1905843A1 (en) * 2006-09-29 2008-04-02 Vlaamse Instelling voor Technologisch Onderzoek Method for determining the allergic potential of a compound
US20090029868A1 (en) * 2006-10-31 2009-01-29 Applera Corporation Expression signature in peripheral blood for detection of aortic aneurysm
GB201018014D0 (en) 2010-10-26 2010-12-08 Senzagen Ab Analytical methods and arrays for use in the same

Also Published As

Publication number Publication date
EP2841599A1 (en) 2015-03-04
US20170283874A1 (en) 2017-10-05
IN2014MN02397A (https=) 2015-08-21
BR112014026582A2 (pt) 2017-06-27
WO2013160882A1 (en) 2013-10-31
KR20150016523A (ko) 2015-02-12
CA2871350A1 (en) 2013-10-31
HK1211059A1 (en) 2016-05-13
US20150111771A1 (en) 2015-04-23
CN104685067A (zh) 2015-06-03
EP2841599A4 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
GB201207297D0 (en) Analytical methods and arrays for use in the same
WO2012056236A3 (en) Analytical methods and arrays for use in the identification of agents inducing sensitization in human skin
MX2015006680A (es) Composiciones y metodos para diagnosticar tumores de tiroides.
EP2554990A4 (en) METHOD OF MEASURING USING IMMUNOCHROMATOGRAPHY, TEST BAND FOR IMMUNOCHROMATOGRAPHY AND KIT OF MEASUREMENT REAGENTS FOR IMMUNOCHROMATOGRAPHY
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
IN2014CN01970A (https=)
BR112016024072A2 (pt) métodos, kits e aparelho para ampliar uma população de células
WO2012120288A3 (en) Method, array and use for determining the presence of pancreatic cancer.
PT2890717T (pt) Ensaios de diagnóstico e kits para deteção de recetor de folato 1
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
BR112013026599A2 (pt) conjunto de bobinas contínuas, dispositivo de teste com conjunto de bobinas contínuas e método de teste
GB201014837D0 (en) Biomarker signatures and uses thereof
BR112017011026A2 (pt) métodos analíticos e arranjos para uso nos mesmos
MX2016005313A (es) Deteccion de la actividad de corte de una enzima.
EP3557259A3 (en) Methods and arrays for use in the same
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
GB201206323D0 (en) Methods and arrays for use in the same
WO2013167727A3 (en) Method for determining arthritis relapse risk
BR112014027490A2 (pt) método de detecção eletroquímica
EP4328324A3 (en) Methods of diagnosing epilepsy
EP2977763A4 (en) Analysis method for assessing stage of prostate cancer, prostate-cancer stage assessment method, prostate-cancer detection method, and test kit
GB201107557D0 (en) Method
WO2012075317A3 (en) Compositions and methods for trichomonas vaginalis diagnostic testing

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)